home / stock / acon / acon articles


ACON Articles, Aclarion Inc. - From 12/21/23

Stock Information

Company Name: Aclarion Inc.
Stock Symbol: ACON
Market: NASDAQ

Menu

ACON ACON Quote ACON Short ACON News ACON Articles ACON Message Board
Get ACON Alerts

News, Short Squeeze, Breakout and More Instantly...

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. KMX reported a t...

Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results. BlackBerry reported qua...

Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results. Steelcase posted upbeat earnings for its...

Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Aclarion, Inc. (NASDAQ: ACON) shares rose sharply in pre-market trading after the company was granted U.S. patent #11844601 for "MR...

Why Gap Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of The Gap, Inc. (NYSE: GPS) jumped in pre-market trading after the company reported better-than-expected financial results for the third ...

Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction. L...

Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withd...

Previous 10 Next 10